Specificity | Clone | Host Species | Reactive Species | Format | Size | Reviews | Supplier | |
---|---|---|---|---|---|---|---|---|
SARS | DM35 | Recombinant Rabbit | n/a | unconjugated | 50 ug, 10 ug, 500 ug, 100 ug | n/a |
BIORBYT LTD. |
More Info |
SARS | DM54 | Recombinant Rabbit | n/a | unconjugated | 100 ug, 500 ug, 50 ug, 10 ug | n/a |
BIORBYT LTD. |
More Info |
SARS | DM55 | Recombinant Rabbit | n/a | unconjugated | 100 ug, 500 ug, 50 ug, 10 ug | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2 RBD | monoclonal | Recombinant Rabbit | SARS-CoV-2 | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 RBD | monoclonal | Recombinant Rabbit | SARS-CoV-2 | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 N Protein | OTI4B9 | Mouse | SARS-CoV-2 | biotin conjugate | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
SARS-CoV-2 N Protein | OTI4B9 | Mouse | SARS-CoV-2 | peroxidase (HRP) conjugate | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
SARS-CoV-2 N Protein | OTI4B9 | Mouse | SARS-CoV-2 | unconjugated | 100 µg | n/a |
ORIGENE TECHNOLOGIES |
More Info |
SARS-CoV-2 N Protein | OTI4B9 | Mouse | SARS-CoV-2 | unconjugated | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
SARS-CoV-2 N Protein | OTI4F8 | Mouse | SARS-CoV-2 | biotin conjugate | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
SARS-CoV-2 N Protein | OTI4F8 | Mouse | SARS-CoV-2 | peroxidase (HRP) conjugate | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
SARS-CoV-2 N Protein | OTI4F8 | Mouse | SARS-CoV-2 | unconjugated | 100 µg | n/a |
ORIGENE TECHNOLOGIES |
More Info |
SARS-CoV-2 N Protein | OTI4F8 | Mouse | SARS-CoV-2 | unconjugated | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
SARS-CoV-2 N Protein | OTI6C3 | Mouse | SARS-CoV-2 | biotin conjugate | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
SARS-CoV-2 N Protein | OTI6C3 | Mouse | SARS-CoV-2 | peroxidase (HRP) conjugate | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
SARS-CoV-2 N Protein | OTI6C3 | Mouse | SARS-CoV-2 | unconjugated | 100 µg | n/a |
ORIGENE TECHNOLOGIES |
More Info |
SARS-CoV-2 N Protein | OTI6C3 | Mouse | SARS-CoV-2 | unconjugated | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
SARS-CoV-2 RBD Neutralizing | OTI1C2 | Mouse | SARS-CoV-2 | biotin conjugate | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
SARS-CoV-2 RBD Neutralizing | OTI1C2 | Mouse | SARS-CoV-2 | peroxidase (HRP) conjugate | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
SARS-CoV-2 RBD Neutralizing | OTI1C2 | Mouse | SARS-CoV-2 | unconjugated | 100 µg | n/a |
ORIGENE TECHNOLOGIES |
More Info |
SARS-CoV-2 RBD Neutralizing | OTI1C2 | Mouse | SARS-CoV-2 | unconjugated | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
SARS-CoV-2 Spike Protein | OTI1H6 | Mouse | SARS-CoV-2 | biotin conjugate | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
SARS-CoV-2 Spike Protein | OTI1H6 | Mouse | SARS-CoV-2 | peroxidase (HRP) conjugate | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
SARS-CoV-2 Spike Protein | OTI1H6 | Mouse | SARS-CoV-2 | unconjugated | 100 µg | n/a |
ORIGENE TECHNOLOGIES |
More Info |
SARS-CoV-2 Spike Protein | OTI1H6 | Mouse | SARS-CoV-2 | unconjugated | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
SARS-CoV-2 Spike Protein | OTI5A7 | Mouse | SARS-CoV-2 | biotin conjugate | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
SARS-CoV-2 Spike Protein | OTI5A7 | Mouse | SARS-CoV-2 | peroxidase (HRP) conjugate | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
SARS-CoV-2 Spike Protein | OTI5A7 | Mouse | SARS-CoV-2 | unconjugated | 100 µg | n/a |
ORIGENE TECHNOLOGIES |
More Info |
SARS-CoV-2 Spike Protein | OTI5A7 | Mouse | SARS-CoV-2 | unconjugated | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
SARS-CoV-2 Spike Protein | OTIR2G9 | Rabbit | SARS-CoV-2 | unconjugated | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
SARS-CoV-2 Spike Protein | OTIR2H1 | Rabbit | SARS-CoV-2 | unconjugated | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
SARS-CoV-2 Spike Protein | OTIR4G6 | Rabbit | SARS-CoV-2 | unconjugated | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
CoV2 Nucleocapsid | polyclonal | Rabbit | n/a | unconjugated | 1 mg, 0.5 mg, 100 ug | n/a |
BIORBYT LTD. |
More Info |
Nucleocapsid CoV-2 | CBP17443 | Mouse | n/a | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 | polyclonal | Human | n/a | plasma | n/a | n/a |
ANTIBODY SYSTEMS INC. |
More Info |
SARS-CoV-2 | polyclonal | Human | n/a | plasma | n/a | n/a |
ANTIBODY SYSTEMS INC. |
More Info |
SARS-CoV-2 | polyclonal | Human | n/a | serum | n/a | n/a |
ANTIBODY SYSTEMS INC. |
More Info |
SARS-CoV-2 | polyclonal | Human | n/a | serum | n/a | n/a |
ANTIBODY SYSTEMS INC. |
More Info |
SARS-CoV-2 | monoclonal | Recombinant Human | SARS-CoV-2 | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 | monoclonal | Recombinant Human | SARS-CoV-2 | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 | monoclonal | Recombinant Human | Severe acute respiratory syndrome coronavirus 2 | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 | monoclonal | Recombinant Human | Severe acute respiratory syndrome coronavirus 2 | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 | monoclonal | Recombinant Human | Severe acute respiratory syndrome coronavirus 2 | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 | monoclonal | Recombinant Human | Severe acute respiratory syndrome coronavirus 2 | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 | monoclonal | Recombinant Human | Severe acute respiratory syndrome coronavirus 2 | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 | monoclonal | Recombinant Human | Severe acute respiratory syndrome coronavirus 2 | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 | monoclonal | Recombinant Human | Severe acute respiratory syndrome coronavirus 2 | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 | monoclonal | Recombinant Human | Severe acute respiratory syndrome coronavirus 2 | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 | monoclonal | Recombinant Human | Severe acute respiratory syndrome coronavirus 2 | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 | monoclonal | Recombinant Human | Severe acute respiratory syndrome coronavirus 2 | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 | monoclonal | Human | n/a | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 | monoclonal | Human | n/a | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 | monoclonal | Recombinant Human | n/a | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 | monoclonal | Recombinant Mouse | n/a | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 | WJ727 | Camelid | SARS-CoV-2 | single domain | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
E Protein | polyclonal | Rabbit | SARS-CoV-2 | unconjugated | 100 µg | n/a |
ORIGENE TECHNOLOGIES |
More Info |
SARS-CoV-2 (COVID-19) Spike P681R | 5H4C5 | Mouse | n/a | unconjugated | 0.1 mg, 0.02 mg | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2 (COVID-19) Spike P681R | 7E3C5 | Mouse | n/a | unconjugated | 0.1 mg | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2 Spike P681H | 1G8D11 | Mouse | n/a | unconjugated | 0.1 mg | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2 Spike P681H | 7A4D12 | Mouse | n/a | unconjugated | 0.1 mg | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2 Spike P681H | 7C11H11 | Mouse | n/a | unconjugated | 0.1 mg | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2 Spike P681H | 9F7E4 | Mouse | n/a | unconjugated | 0.1 mg | n/a |
BIORBYT LTD. |
More Info |
COVID-19 & SARS-CoV S glycoprotein | CR3022 | Human | n/a | purified | 0.2 mg | n/a |
BIORBYT LTD. |
More Info |
COVID-19 & SARS-CoV S glycoprotein | CR3022 | Human | n/a | purified | 0.05 mg | n/a |
BIORBYT LTD. |
More Info |
COVID-19 & SARS-CoV S glycoprotein | CR3022 | Human | n/a | purified | 0.05 mg | n/a |
BIORBYT LTD. |
More Info |
COVID-19 & SARS-CoV S glycoprotein | CR3022 | Human | n/a | purified | 0.2 mg | n/a |
BIORBYT LTD. |
More Info |
COVID-19 & SARS-CoV S glycoprotein | CR3022 | Human | n/a | purified | 0.2 mg | n/a |
BIORBYT LTD. |
More Info |
COVID-19 & SARS-CoV S glycoprotein | CR3022 | Recombinant | n/a | unconjugated | 0.05 mg | n/a |
BIORBYT LTD. |
More Info |
COVID-19 & SARS-CoV S glycoprotein | CR3022 | Recombinant | n/a | unconjugated | 0.2 mg | n/a |
BIORBYT LTD. |
More Info |
COVID-19 & SARS-CoV S glycoprotein | CR3022 | Recombinant | n/a | unconjugated | 0.05 mg | n/a |
BIORBYT LTD. |
More Info |
COVID-19 & SARS-CoV S glycoprotein | CR3022 | Recombinant | n/a | unconjugated | 0.2 mg | n/a |
BIORBYT LTD. |
More Info |
COVID-19 & SARS-CoV S glycoprotein | CR3022 | Recombinant | n/a | unconjugated | 0.2 mg | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2 S RBD | monoclonal | Human | SARS-CoV | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
2019-nCoV NP | polyclonal | Recombinant Rabbit | SARS-CoV-2 (2019-nCoV) | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 (COVID-19) Nucleocapsid | polyclonal | Rabbit | n/a | biotin conjugate | 0.1 mg | n/a |
BIORBYT LTD. |
More Info |